NCT04338425

Patient Satisfaction With Postoperative Communication Modality

Completed NA Last updated 10 April 2020

What this trial tests

NA trial testing Voice call in Surgery in 295 participants. Completed in 20 July 2019.

Timeline

1 December 2018

Primary endpoint
30 June 2019

20 July 2019

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	295
Start date	1 December 2018
Primary completion	30 June 2019
Estimated completion	20 July 2019
Sites	1 location across United States

Drugs / interventions tested

• Voice call
• Video call

Conditions studied

• Surgery — all drugs for Surgery →

Sponsor

NYU Langone Health — full company profile →

Who can join

18 and older, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Communication between a surgeon and a patient in the immediate postoperative period is thought to influence patient satisfaction. There is currently no standard of care regarding the optimal form of postoperative communication, nor is there a consensus in our department as to which modality is preferred by patients.The purpose of this study is to determine which form of communication, if any, is preferred by patients. Furthermore, this study aims to evaluate the impact that various forms of communication during the immediate postoperative period have on patient (subject) satisfaction. The study hypothesizes that patient (subject) satisfaction with their surgeon will be highest among those who communicate with their surgeons via videotelephony (i.e., videoconferencing) and that the lowest satisfaction will be among patients (subjects) who did not communicate with their surgeon until their regularly scheduled postoperative office visit. The results of this study may help identify low cost methods for increasing patient satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.